Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1362 (LINC01362) is a human long non-coding RNA (lncRNA) gene classified as a long intergenic non-coding RNA (lincRNA), meaning it is a transcript longer than 200 nucleotides that does not overlap with protein-coding genes[1][3]. No biological function, disease involvement, or therapeutic targeting has been reported for LINC01362 in the available scientific literature or gene annotation sources[1]. This gene should not be confused with LINC02362, which has preliminary evidence as a tumor suppressor lncRNA in hepatocellular carcinoma[2]. There is no indication that LINC01362 is considered a therapeutic target, nor that it is involved in any recognized pathophysiological or pharmacological process[1]. This target entry appears to be incorrect or not meaningful for drug discovery purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1362 (LINC01362).